News...
Upcoming Trade Shows
Visit us at the CorDynamics booth at our upcoming trade shows.
Exhibiting at the 10th Annual Meeting of the Safety Pharmacology Society, September 20-23, 2010 in Boston, Massachusetts at the World Trade Center — Booth #201.
Recent Press Releases
CorDynamics to Exhibit Proven Cardiovascular Safety and Discovery Solutions at Society of Toxicology Meeting in Salt Lake City
CorDynamics to Exhibit at 2009 Meeting of the American College of Toxicology
CorDynamics Garners Travel Award to Safety Pharmacology Society Meeting in September
CorDynamics to Exhibit at 2009 Safety Pharmacology Society Meeting
CorDynamics and Elixir Pharmaceuticals Will Present at the Drug Safety Strategies to De-Risk Compounds IBC Life Sciences Conference in August
CorDynamics Addresses Current Market Conditions with Affordable Cardiovascular Safety and Discovery Solutions
The CorDynamics team addresses current market conditions and shrinking R&D budgets with affordable cardiovascular safety and discovery solutions.
CorDynamics to Exhibit Affordable Cardiovascular Safety and Discovery Solutions at Society of Toxicology Meeting in Baltimore
CorDynamics looks forward to exhibiting its comprehensive cardiovascular safety and discovery solutions at the upcoming SOT meeting in March. Dr. Gralinski and his team will showcase their ability to deliver isolated heart and screening telemetry results — affordably, quickly and reliably.
CorDynamics Celebrates Five Years in Business
CorDynamics is celebrating its five year anniversary. Now, 25 employees and more than 100 satisfied clients later, the pharmaceutical contract research organization is ready to continue its tradition of providing the best cardiovascular drug discovery and safety assessments in the industry.
CorDynamics Expands Facility to Offer More Telemetry, Anesthetized and Isolated Heart Studies
CorDynamics has dramatically expanded its facility to meet increased client demand for comprehensive cardiovascular drug discovery and pharmaceutical safety testing.
CorDynamics' Second Telemetry Team Meets Increased Market Demands
The second CorDynamics telemetry team continues to provide telemetry studies for clients looking at cardiovascular effects of new molecular entities in a variety of drug development phases.
